Universe Pharmaceuticals INC
UPC
$5.94
-$1.15-16.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 52.67% | 52.67% | 93.89% | 93.89% | 74.93% |
| Total Depreciation and Amortization | -14.24% | -14.24% | 4.65% | 4.65% | 8.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -13.33% | -13.33% | -- |
| Change in Net Operating Assets | -153.34% | -153.34% | -459.05% | -459.05% | 952.66% |
| Cash from Operations | -267.82% | -267.82% | -7.59% | -7.59% | 205.42% |
| Capital Expenditure | -221.28% | -221.28% | 4.60% | 4.60% | -43.20% |
| Sale of Property, Plant, and Equipment | -- | -- | 200.00% | 200.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,071.11% | -4,071.11% | 62.12% | 62.12% | -- |
| Cash from Investing | -1,264.91% | -1,264.91% | 28.81% | 28.81% | -96.45% |
| Total Debt Issued | 70.75% | 70.75% | -19.32% | -19.32% | -70.89% |
| Total Debt Repaid | -437.66% | -437.66% | -104.78% | -104.78% | 37.72% |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.91% | -100.91% | -123.93% | -123.93% | 170.25% |
| Foreign Exchange rate Adjustments | 121.64% | 121.64% | 581.74% | 581.74% | -18,231.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -133.94% | -133.94% | -166.30% | -166.30% | 397.01% |